Heritage Wealth Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Heritage Wealth Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$4.3K	–	581
2022 Q3	$4.3K	Hold	1,000	–	–	﹤0.01%	456
2022 Q2	$5K	Hold	1,000	–	–	﹤0.01%	496
2022 Q1	$12K	Hold	1,000	–	–	﹤0.01%	428
2021 Q4	$20K	Hold	1,000	–	–	﹤0.01%	413
2021 Q3	$26K	Hold	1,000	–	–	﹤0.01%	382
2021 Q2	$22K	Hold	1,000	–	–	﹤0.01%	406
2021 Q1	$23.4K	Hold	1,000	–	–	﹤0.01%	410
2020 Q4	$17K	Hold	1,000	–	–	﹤0.01%	425
2020 Q3	$16.3K	Hold	1,000	–	–	﹤0.01%	368
2020 Q2	$11.5K	Sell	1,000 -500	-33%	-$5.64K	﹤0.01%	372
2020 Q1	$15.1K	Hold	1,500	–	–	﹤0.01%	346
2019 Q4	$16.7K	Buy	+1,500	New	+$25K	﹤0.01%	388

Other funds holding NMTR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

ODFS

O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Heritage Wealth Advisors's NMTR Position: Q4 2022 in Review

Heritage Wealth Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 1,000 shares — an estimated $4.3K sold.

Heritage Wealth Advisors first reported a position in NMTR in Q4 2019 and held it in 12 quarters. The position peaked at $26K in Q3 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

Heritage Wealth Advisors reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
Heritage Wealth Advisors sold 1,000 9 Meters Biopharma shares in Q4 2022, an estimated $4.3K.
Heritage Wealth Advisors first reported a position in 9 Meters Biopharma in Q4 2019 and held it in 12 quarters.
Heritage Wealth Advisors's 9 Meters Biopharma position peaked at $26K in Q3 2021.
42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Heritage Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.